Impact of ERT and follow-up of 17 patients from the same family with a mild form of MPS II

Clinics(2022)

引用 3|浏览11
暂无评分
摘要
•Clinical variability within a large family with a slowly progressive form of MPS II.•Despite being safe, ERT with α or β-Idursulfase might not prevent disease progression.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要